reference/15990295

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15990295

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	605
issn	0008-543X 1097-0142
issueIdentifier	3
pageRange	599-605
publicationName	Cancer
startingPage	599
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_16462efa9e6147c4c8fd885b43c2d213
bibliographicCitation	Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG, Krug LM, Pao W, Pizzo B, Rizvi NA, Miller VA. Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer. Cancer. 2007 Aug 01;110(3):599–605. doi: 10.1002/cncr.22816. PMID: 17577220.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2270e3ace0c5ca2e581a13ac0a79b84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75cc22d8dd1ff7e2307bec0027d680f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87372daab472bb7390d95d710a0a0962 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27f0d846d0a580a52d2ad7cc7a62171b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b2fdf55b585d82de7a75fa8d939b7e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b15545f0a9fb8aaef1dbdabbae26e29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14b4f28392fbdfa9a18599cfad35eeca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee5afcab92401cedd68336557f9f46e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75df2e418a218b000200655595610026 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b65b312652d21187d3c0d5ee5896f4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96e35f40ed7f4b59cda0ea6fc8035e29
date	2007-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1002/cncr.22816 https://pubmed.ncbi.nlm.nih.gov/17577220
isPartOf	https://portal.issn.org/resource/ISSN/0008-543X https://portal.issn.org/resource/ISSN/1097-0142 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0444984 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0029863
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000493 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D002294Q000188 http://id.nlm.nih.gov/mesh/D002294Q000473 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000077156 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8135 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350

Total number of triples: 74.